StreetInsider.com News Articles

Novo Nordisk (NVO) call put ratio 1.9 calls to 1 put amid price movement

Wed, 21 Oct 2026 05:10:59 -0400

Novo Nordisk (NYSE: NVO) 30-day option implied volatility is at 39; compared to its 52-week range of 29 to 64. Call put ratio 1.9 calls to 1 put amid price movement.

Novo Nordisk CagriSema trial data show weight loss in women by menopause stage

Tue, 20 Oct 2026 09:17:47 -0400

Novo Nordisk (NYSE: NVO) presented results from two post hoc analyses of its REDEFINE 1 trial at The Menopause Society 2026 Annual Meeting in San Diego, examining the investigational drug CagriSema across women with obesity or overweight.

In the first analysis of 2,309 women, CagriSema 2.4 mg / 2.4 mg was associated with an average weight loss of 25.0% at week 68 under an efficacy estimand, compared with 3.0% for placebo. The combination also showed a reduction in waist circumference of 20.5 cm versus 4.7 cm with placebo. Among CagriSema-treated participants, 93.3% achieved at least 10% body weight loss and 68.7%

Novo Nordisk CagriSema trial data show weight loss in women by menopause stage

Tue, 20 Oct 2026 09:17:47 -0400

Novo Nordisk CagriSema trial data show weight loss in women by menopause stage

Tue, 20 Oct 2026 09:17:47 -0400

Novo Nordisk CagriSema trial data show weight loss in women by menopause stage

Tue, 20 Oct 2026 09:17:47 -0400

Telsey analyzes GLP-1 drugs' impact on consumer sector

Tue, 20 Oct 2026 07:50:49 -0400

Investing.com -- Telsey released a report examining how GLP-1 medications are affecting consumer spending patterns across multiple retail categories. The drugs, first approved by the FDA in 2005 for type 2 diabetes treatment, have gained widespread adoption in recent years.

GLP-1 medications include semaglutide, sold as Ozempic and Rybelsus for diabetes and Wegovy for obesity, and tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity. The drugs work by stimulating insulin release, reducing blood sugar, slowing digestion, and reducing hunger.

Companies covered by Telsey have reported changes in consumer behavior related to GLP-1 use, including purchases of new wardrobes, products to

Telsey analyzes GLP-1 drugs' impact on consumer sector

Tue, 20 Oct 2026 07:50:49 -0400

Companies covered by Telsey have reported changes in consumer behavior related to GLP-1 use, including purchases of new wardrobes, products to

Telsey analyzes GLP-1 drugs' impact on consumer sector

Tue, 20 Oct 2026 07:50:49 -0400

Companies covered by Telsey have reported changes in consumer behavior related to GLP-1 use, including purchases of new wardrobes, products to

Telsey analyzes GLP-1 drugs' impact on consumer sector

Tue, 20 Oct 2026 07:50:49 -0400

Companies covered by Telsey have reported changes in consumer behavior related to GLP-1 use, including purchases of new wardrobes, products to

Form 6-K NOVO NORDISK A S For: Oct 19

Mon, 19 Oct 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20261019/27201231.html

Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK280 at HSBC

Mon, 19 Oct 2026 01:31:53 -0400

HSBC analyst Rajesh Kumar lowered the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK280.00 (from DKK320.00) while maintaining a Hold rating.

Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK280 at HSBC

Mon, 19 Oct 2026 01:31:53 -0400

HSBC analyst Rajesh Kumar lowered the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK280.00 (from DKK320.00) while maintaining a Hold rating.

Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK280 at HSBC

Mon, 19 Oct 2026 01:31:53 -0400

HSBC analyst Rajesh Kumar lowered the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK280.00 (from DKK320.00) while maintaining a Hold rating.

Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK280 at HSBC

Mon, 19 Oct 2026 01:31:53 -0400

HSBC analyst Rajesh Kumar lowered the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK280.00 (from DKK320.00) while maintaining a Hold rating.

Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Fri, 16 Oct 2026 08:35:00 -0400

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Precious Metals & Critical Minerals Virtual Investor Conference, held October 13th –15th, 2026, are now available for on-demand viewing. The event was co-sponsored by Skyline Corporate Communications.